Back
  1. Home
  2. Profile of France Bruck (ULiège)
Profil

Bruck France

See author's contact details
Main Referenced Co-authors
Baron, Frédéric  (2)
Beguin, Yves  (2)
Baudoux, Etienne  (1)
Belle, Ludovic  (1)
Briquet, Alexandra  (1)
Main Referenced Keywords
graft-versus-host disease (2); mesenchymal stem cells (2); cellules souches mésenchymateuses (1); graft-versus-tumor effects (1); hematopoietic cell transplantation (1);
Main Referenced Disciplines
Hematology (3)

Publications (total 3)

The most downloaded
38 downloads
Belle, L., Baron, F., Bruck, F., Hannon, M., Servais, S., Beguin, Y., & BRIQUET, A. (2011). Despite Inhibitory Effects on Normal Hematopoiesis in Vitro, Imatinib and Nilotinib do not Prevent Engraftment of Human CD34+ HSCs in immunodeficient NSG Mice [Poster presentation]. 26th General Meeting of the Belgian Hematological Society. https://hdl.handle.net/2268/148877

The most cited

176 citations (Scopus®)

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011 https://hdl.handle.net/2268/77204

Bruck, F. (2013). Impact des cellules souches mésenchymateuses et de la rapamycine sur la maladie du greffon contre l'hôte xénogénique [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315102

Belle, L., Baron, F., Bruck, F., Hannon, M., Servais, S., Beguin, Y., & BRIQUET, A. (2011). Despite Inhibitory Effects on Normal Hematopoiesis in Vitro, Imatinib and Nilotinib do not Prevent Engraftment of Human CD34+ HSCs in immunodeficient NSG Mice [Poster presentation]. 26th General Meeting of the Belgian Hematological Society.

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011
Peer Reviewed verified by ORBi

Contact ORBi